These molecules, especially PR3, have been demonstrated to reduce expression of rhodopsin and other rod genes and modify disease progression in mouse models of rod photoreceptor mutation-associated RP (; Nakamura et al., 2016; Nakamura et al., 2017). This evidence concerns the gene PRTN3 and retinitis pigmentosa 1.